Innoviva, Inc.
SEC CIK 1080014 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | Dir, 10% | 16.37M | $26.93M | — | 1 | 2022-03-31 | 2022-03-31 |
Most active insiders at ARMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kyme Pierre | Chief Business Off | — | — |
| 2 | Birx Deborah | CEO, Dir | — | — |
Innoviva, Inc. made no open-market trades at ARMP in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-04-01 | 2022-03-31 | ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | Dir, 10% | P - Purchase | $5.00 | +5.39M | 16.37M | +49% | +$26.93M |
Purchase Sale Sale after option exercise All abbreviations